Hyperion DeFi (NASDAQ:HYPD) Announces Quarterly Earnings Results

Hyperion DeFi (NASDAQ:HYPD) announced its quarterly earnings results on Thursday. The company reported $0.92 earnings per share for the quarter, Zacks reports. The firm had revenue of $0.36 million for the quarter. Hyperion DeFi had a net margin of 416.56% and a negative return on equity of 13.93%.

Hyperion DeFi Stock Down 3.9%

Shares of NASDAQ:HYPD traded down $0.11 during midday trading on Friday, hitting $2.72. The stock had a trading volume of 155,025 shares, compared to its average volume of 218,881. Hyperion DeFi has a 12 month low of $2.34 and a 12 month high of $15.00. The company has a quick ratio of 1.97, a current ratio of 1.97 and a debt-to-equity ratio of 0.12. The business’s 50-day simple moving average is $2.90 and its 200-day simple moving average is $3.35. The company has a market cap of $41.23 million, a P/E ratio of -0.42 and a beta of 2.53.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on HYPD. Weiss Ratings upgraded shares of Hyperion DeFi from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, June 24th. Cantor Fitzgerald increased their target price on Hyperion DeFi from $6.60 to $7.10 and gave the stock an “overweight” rating in a report on Thursday. Chardan Capital restated a “buy” rating and issued a $7.30 price target on shares of Hyperion DeFi in a report on Tuesday. Finally, Zacks Research cut Hyperion DeFi from a “hold” rating to a “strong sell” rating in a research report on Wednesday. Two analysts have rated the stock with a Buy rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $7.20.

Insider Transactions at Hyperion DeFi

In other news, insider Hyunsu Jung purchased 7,000 shares of the business’s stock in a transaction on Monday, June 1st. The stock was purchased at an average price of $3.70 per share, for a total transaction of $25,900.00. Following the completion of the purchase, the insider directly owned 1,384,676 shares in the company, valued at $5,123,301.20. The trade was a 0.51% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 7.50% of the company’s stock.

Institutional Investors Weigh In On Hyperion DeFi

Hedge funds have recently bought and sold shares of the company. Renaissance Technologies LLC acquired a new position in Hyperion DeFi during the fourth quarter worth approximately $663,000. Jane Street Group LLC acquired a new stake in shares of Hyperion DeFi in the fourth quarter valued at approximately $493,000. Focus Partners Advisor Solutions LLC bought a new position in shares of Hyperion DeFi during the 4th quarter worth approximately $221,000. Geode Capital Management LLC acquired a new position in shares of Hyperion DeFi during the 4th quarter worth approximately $214,000. Finally, State Street Corp bought a new stake in Hyperion DeFi in the 4th quarter valued at $92,000. 25.84% of the stock is currently owned by institutional investors and hedge funds.

About Hyperion DeFi

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.